Urologists and other physicians who serve Medicare patients face some new decisions now that the Centers for Medicare & Medicaid Services has proposed new regulations implementing last year’s fee schedule reform law, while also replacing the existing meaningful use program with a more flexible approach to technology and electronic health records.
“Few physicians are familiar with apology law and even fewer understand the significance,” said Patrick McKenna, MD, chief of the division of pediatric urology at American Family Children’s Hospital and professor of urology at the University of Wisconsin, Madison.
In a series of articles this year, Robert A. Dowling, MD, will examine what you need to know about the law, what the CMS proposed rule for implementation implies for the near and long-term future, and—when it is issued later this year—what the final rule means to your urology practice.
The ACA is a large step forward in allowing men to embrace their health concerns, and for health care practitioners to understand men and the challenge of help seeking, masculinity, and disparity in their quest for wellness (Men’s Health in Primary Care [Current Clinical Practice]. Switzerland: Springer International Publishing, 2016).
"As evidenced by the flurry of activity at the state and federal levels of government, many physicians are fighting back against increasingly burdensome recertification requirements," writes the AACU's Ross E. Weber.
As a result of strong opposition from organized medicine, including the AUA and patients, the Centers for Medicare & Medicaid Services has put on hold its development of a draft plan to penalize physicians for ordering “non-recommended” PSA tests to screen for prostate cancer.